Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.

O'Neill TJ, Rivera L, Struchkov V, Zaheen A, Thein HH.

PLoS One. 2014 Jul 17;9(7):e101493. doi: 10.1371/journal.pone.0101493. eCollection 2014.

2.

Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.

Dong HV, Cortés YI, Shiau S, Yin MT.

AIDS. 2014 Sep 10;28(14):2119-31. Review.

3.

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Lo Re V 3rd, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR.

Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866. Epub 2012 Oct 14.

4.

Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1.

5.

Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients.

Linari S, Montorzi G, Bartolozzi D, Borderi M, Melchiorre D, Benelli M, Morfini M.

Haemophilia. 2013 Jan;19(1):126-33. doi: 10.1111/j.1365-2516.2012.02899.x. Epub 2012 Jul 9.

PMID:
22776099
6.

Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.

Bedimo R, Maalouf NM, Lo Re V 3rd.

Curr Opin HIV AIDS. 2016 May;11(3):285-93. doi: 10.1097/COH.0000000000000259. Review.

PMID:
26890206
7.

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.

Brown TT, Qaqish RB.

AIDS. 2006 Nov 14;20(17):2165-74. Review.

PMID:
17086056
8.

Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients.

Maalouf NM, Zhang S, Drechsler H, Brown GR, Tebas P, Bedimo R.

J Bone Miner Res. 2013 Dec;28(12):2577-83. doi: 10.1002/jbmr.1988.

9.

Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.

Borghi V, Bisi L, Manzini L, Cossarizza A, Mussini C.

Infection. 2013 Apr;41(2):425-9. doi: 10.1007/s15010-012-0378-7. Epub 2012 Dec 9.

PMID:
23225268
10.

Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.

Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS.

Lancet Infect Dis. 2015 Jul;15(7):819-24. doi: 10.1016/S1473-3099(15)00006-7. Epub 2015 May 5. Review.

PMID:
25957078
11.

Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1.

Moreira M, Ramos A, Netto EM, Brites C.

Braz J Infect Dis. 2013 Nov-Dec;17(6):661-6. doi: 10.1016/j.bjid.2013.04.009. Epub 2013 Sep 9.

12.

Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.

Fabrizi F, Dixit V, Martin P, Messa P.

J Med Virol. 2016 Mar;88(3):487-97. doi: 10.1002/jmv.24353. Epub 2015 Oct 8. Review.

PMID:
26271205
13.

Is hand-grip another culprit for the risk of fractures in HIV-positive patients?

Postorino MC, Torti C, Carè I, Pisani V, Strazzulla A, Vaccaro V, Costa C, Provenzano F, Mazzitelli M, Pujia A, Montalcini T.

New Microbiol. 2016 Jan;39(1):61-4.

14.

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.

Casado JL, Bañon S, Andrés R, Perez-Elías MJ, Moreno A, Moreno S.

Osteoporos Int. 2014 Mar;25(3):1071-9. doi: 10.1007/s00198-013-2506-3. Epub 2013 Sep 21.

PMID:
24057480
15.

Low bone mineral density and risk of incident fracture in HIV-infected adults.

Battalora L, Buchacz K, Armon C, Overton ET, Hammer J, Patel P, Chmiel JS, Wood K, Bush TJ, Spear JR, Brooks JT, Young B; HIV Outpatient Study (HOPS) and SUN Study Investigators..

Antivir Ther. 2016;21(1):45-54. doi: 10.3851/IMP2979. Epub 2015 Jul 21.

PMID:
26194468
16.

Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study.

Hansen AB, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Obel N.

AIDS. 2012 Jan 28;26(3):285-93. doi: 10.1097/QAD.0b013e32834ed8a7.

PMID:
22095195
17.

Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.

Li Vecchi V, Soresi M, Giannitrapani L, Mazzola G, La Sala S, Tramuto F, Caruso G, Colomba C, Mansueto P, Madonia S, Montalto G, Di Carlo P.

BMC Infect Dis. 2012 Aug 15;12:192.

18.

Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.

Mwatelah RS, Lwembe RM, Osman S, Ogutu BR, Aman R, Kitawi RC, Wangai LN, Oloo FA, Kokwaro GO, Ochieng W.

PLoS One. 2015 Jul 24;10(7):e0132287. doi: 10.1371/journal.pone.0132287. eCollection 2015.

19.

Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort.

Lawson-Ayayi S, Cazanave C, Kpozehouen A, Barthe N, Mehsen N, Hessamfar M, Dupon M, Dabis F, Neau D; Groupe Epidémiologie Clinique du SIDA en Aquitaine (GECSA)..

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):430-5. doi: 10.1097/QAI.0b013e3182845d88.

PMID:
23296138
20.

Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.

Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P, Prezelj J, Vidmar G, Vidmar L.

Wien Klin Wochenschr. 2007;119(21-22):639-46.

PMID:
18043884

Supplemental Content

Support Center